Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Clinlcal significance of transforming growth factor-beta1 in the diagnosis of hepatocellular carcinoma associated with hcv infection

Telomerase activity in peripheral blood in chronic hepatitis and hepatocellular carcinoma

Role of hepatocyte growth factor in hepatitis c patients on dialysis

Role of hepatocyte growth factor in hepatitis c patients on dialysis

Histopathological study of vascular endothelial growth factor expression in hepatocellular carcinoma

Expression of hepatocyte paraffin 1 antibody and vascular endothelial growth factor in hepatocellular carcinoma and chronic viral hepatitis : An immunohistochemcial study

Significance of hepatocyte growth factor (HGF) concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma

Epidermal growth factor (EGF) gene polymorphism as a risk factor for development of hepatocellular carcinoma (HCC) in chronic liver disease patients